Tag: CD44v6-targeting antibody
Akiram Therapeutics research selected as Top Rated Oral Presentations at EANM...
Akiram Therapeutics, a Swedish biotech company specializing in targeted radiotherapy, will contribute to several academic presentations at the EANM Congress 2025 in Barcelona, October...